nodes	percent_of_prediction	percent_of_DWPC	metapath
Fusidic Acid—ABCB11—Doxorubicin—thyroid cancer	0.358	0.418	CbGbCtD
Fusidic Acid—ABCC2—Sorafenib—thyroid cancer	0.31	0.362	CbGbCtD
Fusidic Acid—ABCC2—Doxorubicin—thyroid cancer	0.188	0.22	CbGbCtD
Fusidic Acid—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00353	0.0247	CcSEcCtD
Fusidic Acid—Bone disorder—Sorafenib—thyroid cancer	0.00345	0.0242	CcSEcCtD
Fusidic Acid—Lethargy—Vandetanib—thyroid cancer	0.00343	0.024	CcSEcCtD
Fusidic Acid—Drug interaction—Sorafenib—thyroid cancer	0.00336	0.0235	CcSEcCtD
Fusidic Acid—Neutropenia—Vandetanib—thyroid cancer	0.00271	0.019	CcSEcCtD
Fusidic Acid—Conjunctivitis—Vandetanib—thyroid cancer	0.00252	0.0176	CcSEcCtD
Fusidic Acid—Renal failure acute—Sorafenib—thyroid cancer	0.00245	0.0172	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00245	0.0171	CcSEcCtD
Fusidic Acid—Eye disorder—Vandetanib—thyroid cancer	0.00217	0.0152	CcSEcCtD
Fusidic Acid—Arrhythmia—Vandetanib—thyroid cancer	0.00208	0.0145	CcSEcCtD
Fusidic Acid—Abdominal pain upper—Sorafenib—thyroid cancer	0.00207	0.0145	CcSEcCtD
Fusidic Acid—Lacrimation—Epirubicin—thyroid cancer	0.00196	0.0137	CcSEcCtD
Fusidic Acid—Vision blurred—Vandetanib—thyroid cancer	0.00191	0.0133	CcSEcCtD
Fusidic Acid—Neutropenia—Sorafenib—thyroid cancer	0.00183	0.0128	CcSEcCtD
Fusidic Acid—Lacrimation—Doxorubicin—thyroid cancer	0.00181	0.0127	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00171	0.012	CcSEcCtD
Fusidic Acid—Redness—Epirubicin—thyroid cancer	0.00171	0.012	CcSEcCtD
Fusidic Acid—Jaundice—Sorafenib—thyroid cancer	0.0017	0.0119	CcSEcCtD
Fusidic Acid—Burning sensation—Epirubicin—thyroid cancer	0.00166	0.0116	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00165	0.0115	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Vandetanib—thyroid cancer	0.00162	0.0113	CcSEcCtD
Fusidic Acid—Skin disorder—Vandetanib—thyroid cancer	0.0016	0.0112	CcSEcCtD
Fusidic Acid—Redness—Doxorubicin—thyroid cancer	0.00158	0.0111	CcSEcCtD
Fusidic Acid—Burning sensation—Doxorubicin—thyroid cancer	0.00154	0.0107	CcSEcCtD
Fusidic Acid—Dyspepsia—Vandetanib—thyroid cancer	0.00145	0.0102	CcSEcCtD
Fusidic Acid—Decreased appetite—Vandetanib—thyroid cancer	0.00143	0.01	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00142	0.00997	CcSEcCtD
Fusidic Acid—Stinging—Epirubicin—thyroid cancer	0.00142	0.00996	CcSEcCtD
Fusidic Acid—Immune system disorder—Sorafenib—thyroid cancer	0.00142	0.0099	CcSEcCtD
Fusidic Acid—Pain—Vandetanib—thyroid cancer	0.00141	0.00987	CcSEcCtD
Fusidic Acid—Arrhythmia—Sorafenib—thyroid cancer	0.0014	0.00979	CcSEcCtD
Fusidic Acid—Erythema—Sorafenib—thyroid cancer	0.00136	0.00954	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00135	0.00944	CcSEcCtD
Fusidic Acid—Stinging—Doxorubicin—thyroid cancer	0.00132	0.00921	CcSEcCtD
Fusidic Acid—Abdominal pain—Vandetanib—thyroid cancer	0.0013	0.00913	CcSEcCtD
Fusidic Acid—Bone disorder—Epirubicin—thyroid cancer	0.00128	0.00893	CcSEcCtD
Fusidic Acid—Anaemia—Sorafenib—thyroid cancer	0.00126	0.00882	CcSEcCtD
Fusidic Acid—Lacrimation increased—Epirubicin—thyroid cancer	0.00125	0.00875	CcSEcCtD
Fusidic Acid—Angioedema—Sorafenib—thyroid cancer	0.00125	0.00872	CcSEcCtD
Fusidic Acid—Leukopenia—Sorafenib—thyroid cancer	0.00122	0.00854	CcSEcCtD
Fusidic Acid—Inflammation—Epirubicin—thyroid cancer	0.00119	0.00832	CcSEcCtD
Fusidic Acid—Bone disorder—Doxorubicin—thyroid cancer	0.00118	0.00826	CcSEcCtD
Fusidic Acid—Pruritus—Vandetanib—thyroid cancer	0.00117	0.00817	CcSEcCtD
Fusidic Acid—Lacrimation increased—Doxorubicin—thyroid cancer	0.00116	0.0081	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00115	0.00807	CcSEcCtD
Fusidic Acid—Diarrhoea—Vandetanib—thyroid cancer	0.00113	0.0079	CcSEcCtD
Fusidic Acid—Inflammation—Doxorubicin—thyroid cancer	0.0011	0.0077	CcSEcCtD
Fusidic Acid—Dizziness—Vandetanib—thyroid cancer	0.00109	0.00764	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Sorafenib—thyroid cancer	0.00109	0.00763	CcSEcCtD
Fusidic Acid—Skin disorder—Sorafenib—thyroid cancer	0.00108	0.00757	CcSEcCtD
Fusidic Acid—Anorexia—Sorafenib—thyroid cancer	0.00106	0.00742	CcSEcCtD
Fusidic Acid—Vomiting—Vandetanib—thyroid cancer	0.00105	0.00734	CcSEcCtD
Fusidic Acid—Rash—Vandetanib—thyroid cancer	0.00104	0.00728	CcSEcCtD
Fusidic Acid—Dermatitis—Vandetanib—thyroid cancer	0.00104	0.00727	CcSEcCtD
Fusidic Acid—Headache—Vandetanib—thyroid cancer	0.00103	0.00723	CcSEcCtD
Fusidic Acid—Nausea—Vandetanib—thyroid cancer	0.00098	0.00686	CcSEcCtD
Fusidic Acid—Dyspepsia—Sorafenib—thyroid cancer	0.00098	0.00686	CcSEcCtD
Fusidic Acid—Decreased appetite—Sorafenib—thyroid cancer	0.000968	0.00677	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Epirubicin—thyroid cancer	0.000967	0.00677	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000961	0.00672	CcSEcCtD
Fusidic Acid—Pain—Sorafenib—thyroid cancer	0.000952	0.00666	CcSEcCtD
Fusidic Acid—Eye pain—Epirubicin—thyroid cancer	0.000927	0.00649	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00091	0.00637	CcSEcCtD
Fusidic Acid—Renal failure acute—Epirubicin—thyroid cancer	0.000907	0.00634	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000895	0.00626	CcSEcCtD
Fusidic Acid—Urticaria—Sorafenib—thyroid cancer	0.000884	0.00619	CcSEcCtD
Fusidic Acid—Abdominal pain—Sorafenib—thyroid cancer	0.00088	0.00616	CcSEcCtD
Fusidic Acid—Eye pain—Doxorubicin—thyroid cancer	0.000858	0.006	CcSEcCtD
Fusidic Acid—Lethargy—Epirubicin—thyroid cancer	0.000854	0.00598	CcSEcCtD
Fusidic Acid—Renal failure acute—Doxorubicin—thyroid cancer	0.000839	0.00587	CcSEcCtD
Fusidic Acid—Hypersensitivity—Sorafenib—thyroid cancer	0.00082	0.00574	CcSEcCtD
Fusidic Acid—Lethargy—Doxorubicin—thyroid cancer	0.00079	0.00553	CcSEcCtD
Fusidic Acid—Pruritus—Sorafenib—thyroid cancer	0.000788	0.00551	CcSEcCtD
Fusidic Acid—Abdominal pain upper—Epirubicin—thyroid cancer	0.000765	0.00535	CcSEcCtD
Fusidic Acid—Diarrhoea—Sorafenib—thyroid cancer	0.000762	0.00533	CcSEcCtD
Fusidic Acid—Muscular weakness—Epirubicin—thyroid cancer	0.000738	0.00517	CcSEcCtD
Fusidic Acid—Dizziness—Sorafenib—thyroid cancer	0.000736	0.00515	CcSEcCtD
Fusidic Acid—Vomiting—Sorafenib—thyroid cancer	0.000708	0.00495	CcSEcCtD
Fusidic Acid—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000707	0.00495	CcSEcCtD
Fusidic Acid—Rash—Sorafenib—thyroid cancer	0.000702	0.00491	CcSEcCtD
Fusidic Acid—Dermatitis—Sorafenib—thyroid cancer	0.000701	0.00491	CcSEcCtD
Fusidic Acid—Headache—Sorafenib—thyroid cancer	0.000697	0.00488	CcSEcCtD
Fusidic Acid—Pancytopenia—Epirubicin—thyroid cancer	0.000687	0.00481	CcSEcCtD
Fusidic Acid—Muscular weakness—Doxorubicin—thyroid cancer	0.000683	0.00478	CcSEcCtD
Fusidic Acid—Neutropenia—Epirubicin—thyroid cancer	0.000677	0.00473	CcSEcCtD
Fusidic Acid—Nausea—Sorafenib—thyroid cancer	0.000661	0.00463	CcSEcCtD
Fusidic Acid—Pancytopenia—Doxorubicin—thyroid cancer	0.000636	0.00445	CcSEcCtD
Fusidic Acid—Jaundice—Epirubicin—thyroid cancer	0.000629	0.0044	CcSEcCtD
Fusidic Acid—Conjunctivitis—Epirubicin—thyroid cancer	0.000627	0.00439	CcSEcCtD
Fusidic Acid—Neutropenia—Doxorubicin—thyroid cancer	0.000626	0.00438	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00061	0.00427	CcSEcCtD
Fusidic Acid—Agranulocytosis—Epirubicin—thyroid cancer	0.000602	0.00421	CcSEcCtD
Fusidic Acid—Jaundice—Doxorubicin—thyroid cancer	0.000582	0.00407	CcSEcCtD
Fusidic Acid—Conjunctivitis—Doxorubicin—thyroid cancer	0.00058	0.00406	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000565	0.00395	CcSEcCtD
Fusidic Acid—Agranulocytosis—Doxorubicin—thyroid cancer	0.000557	0.0039	CcSEcCtD
Fusidic Acid—Eye disorder—Epirubicin—thyroid cancer	0.000541	0.00379	CcSEcCtD
Fusidic Acid—Immune system disorder—Epirubicin—thyroid cancer	0.000523	0.00366	CcSEcCtD
Fusidic Acid—Arrhythmia—Epirubicin—thyroid cancer	0.000517	0.00362	CcSEcCtD
Fusidic Acid—Erythema—Epirubicin—thyroid cancer	0.000504	0.00353	CcSEcCtD
Fusidic Acid—Eye disorder—Doxorubicin—thyroid cancer	0.000501	0.0035	CcSEcCtD
Fusidic Acid—Flatulence—Epirubicin—thyroid cancer	0.000497	0.00348	CcSEcCtD
Fusidic Acid—Immune system disorder—Doxorubicin—thyroid cancer	0.000484	0.00339	CcSEcCtD
Fusidic Acid—Arrhythmia—Doxorubicin—thyroid cancer	0.000479	0.00335	CcSEcCtD
Fusidic Acid—Vision blurred—Epirubicin—thyroid cancer	0.000475	0.00332	CcSEcCtD
Fusidic Acid—Erythema—Doxorubicin—thyroid cancer	0.000466	0.00326	CcSEcCtD
Fusidic Acid—Anaemia—Epirubicin—thyroid cancer	0.000466	0.00326	CcSEcCtD
Fusidic Acid—Flatulence—Doxorubicin—thyroid cancer	0.00046	0.00322	CcSEcCtD
Fusidic Acid—Leukopenia—Epirubicin—thyroid cancer	0.000451	0.00316	CcSEcCtD
Fusidic Acid—Vision blurred—Doxorubicin—thyroid cancer	0.00044	0.00308	CcSEcCtD
Fusidic Acid—Anaemia—Doxorubicin—thyroid cancer	0.000431	0.00302	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000426	0.00298	CcSEcCtD
Fusidic Acid—Discomfort—Epirubicin—thyroid cancer	0.000424	0.00297	CcSEcCtD
Fusidic Acid—Leukopenia—Doxorubicin—thyroid cancer	0.000418	0.00292	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Epirubicin—thyroid cancer	0.000403	0.00282	CcSEcCtD
Fusidic Acid—Skin disorder—Epirubicin—thyroid cancer	0.0004	0.0028	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000394	0.00276	CcSEcCtD
Fusidic Acid—Discomfort—Doxorubicin—thyroid cancer	0.000392	0.00274	CcSEcCtD
Fusidic Acid—Anorexia—Epirubicin—thyroid cancer	0.000392	0.00274	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000373	0.00261	CcSEcCtD
Fusidic Acid—Skin disorder—Doxorubicin—thyroid cancer	0.00037	0.00259	CcSEcCtD
Fusidic Acid—Anorexia—Doxorubicin—thyroid cancer	0.000363	0.00254	CcSEcCtD
Fusidic Acid—Dyspepsia—Epirubicin—thyroid cancer	0.000362	0.00253	CcSEcCtD
Fusidic Acid—Decreased appetite—Epirubicin—thyroid cancer	0.000358	0.0025	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000355	0.00249	CcSEcCtD
Fusidic Acid—Pain—Epirubicin—thyroid cancer	0.000352	0.00246	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000336	0.00235	CcSEcCtD
Fusidic Acid—Dyspepsia—Doxorubicin—thyroid cancer	0.000335	0.00234	CcSEcCtD
Fusidic Acid—Decreased appetite—Doxorubicin—thyroid cancer	0.000331	0.00232	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000329	0.0023	CcSEcCtD
Fusidic Acid—Urticaria—Epirubicin—thyroid cancer	0.000327	0.00229	CcSEcCtD
Fusidic Acid—Pain—Doxorubicin—thyroid cancer	0.000326	0.00228	CcSEcCtD
Fusidic Acid—Abdominal pain—Epirubicin—thyroid cancer	0.000325	0.00228	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000311	0.00218	CcSEcCtD
Fusidic Acid—Hypersensitivity—Epirubicin—thyroid cancer	0.000303	0.00212	CcSEcCtD
Fusidic Acid—Urticaria—Doxorubicin—thyroid cancer	0.000302	0.00212	CcSEcCtD
Fusidic Acid—Abdominal pain—Doxorubicin—thyroid cancer	0.000301	0.00211	CcSEcCtD
Fusidic Acid—Pruritus—Epirubicin—thyroid cancer	0.000291	0.00204	CcSEcCtD
Fusidic Acid—Diarrhoea—Epirubicin—thyroid cancer	0.000282	0.00197	CcSEcCtD
Fusidic Acid—Hypersensitivity—Doxorubicin—thyroid cancer	0.000281	0.00196	CcSEcCtD
Fusidic Acid—Dizziness—Epirubicin—thyroid cancer	0.000272	0.0019	CcSEcCtD
Fusidic Acid—Pruritus—Doxorubicin—thyroid cancer	0.000269	0.00188	CcSEcCtD
Fusidic Acid—Vomiting—Epirubicin—thyroid cancer	0.000262	0.00183	CcSEcCtD
Fusidic Acid—Diarrhoea—Doxorubicin—thyroid cancer	0.00026	0.00182	CcSEcCtD
Fusidic Acid—Rash—Epirubicin—thyroid cancer	0.000259	0.00181	CcSEcCtD
Fusidic Acid—Dermatitis—Epirubicin—thyroid cancer	0.000259	0.00181	CcSEcCtD
Fusidic Acid—Headache—Epirubicin—thyroid cancer	0.000258	0.0018	CcSEcCtD
Fusidic Acid—Dizziness—Doxorubicin—thyroid cancer	0.000252	0.00176	CcSEcCtD
Fusidic Acid—Nausea—Epirubicin—thyroid cancer	0.000244	0.00171	CcSEcCtD
Fusidic Acid—Vomiting—Doxorubicin—thyroid cancer	0.000242	0.00169	CcSEcCtD
Fusidic Acid—Rash—Doxorubicin—thyroid cancer	0.00024	0.00168	CcSEcCtD
Fusidic Acid—Dermatitis—Doxorubicin—thyroid cancer	0.00024	0.00168	CcSEcCtD
Fusidic Acid—Headache—Doxorubicin—thyroid cancer	0.000239	0.00167	CcSEcCtD
Fusidic Acid—Nausea—Doxorubicin—thyroid cancer	0.000226	0.00158	CcSEcCtD
